Abstract
Ruxolitinib or Dasatinib in Combination with Chemotherapy for Patients with Relapsed/Refractory Philadelphia (Ph)-like Acute Lymphoblastic Leukemia: A Phase I-II Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have